| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.77 | 0.07 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |